Background: Sjögren syndrome (SS) is an autoimmune exocrinopathy in which patients produce autoantibodies against the antigen α-fodrin. In the murine model the antigen that elicits the antibody response is a 120 kDacleaved α-fodrin fragment. In a human salivary gland (HSG) ductal cell in vitro model the α-chain of the protein fodrin is cleaved following TNF-induced apoptosis to yield a cleaved product. Cleaved α-fodrin is presented on the cell surface suggesting a mechanism for antigen recognition in vivo as well as a potential antigen of value in diagnosis. The objective of this study was to test the hypothesis that cleaved α-fodrin is expressed in minor salivary gland biopsies and saliva in vivo.
Introduction
Sjögren syndrome (SS) is characterized by lymphocytic infiltration of the salivary and lacrimal glands by CD4 + T lymphocytes, loss or "drop out" of acinar secretory cells, and eventual fibrosis and destruction of the gland [1, 2] . Sjögren syndrome is an autoimmune disease, producing a range of autoantibodiesand cytokines leading to apoptosis of salivary and lacrimal tissues [1] [2] [3] [4] [5] . Current diagnostic tests are unable to render a specific diagnosis of SS and thus there is a need for improved diagnostic tools. It would therefore be of value to identify a biomarker suitable for the early diagnosis and monitoring of tissue destruction. A more thorough understanding of the mechanism that leads to the destruction of salivary and lacrimal glands in SS may also improve the quality of life in patients and open new avenues for the development of novel diagnostic tools and therapies.
Many studies have demonstrated that apoptosis is involved in the potential mechanism for the development of autoimmune diseases [6] [7] [8] [9] [10] . The increase in proteolytic activity during apoptosis provokes degradation of cellular or nuclear proteins, some of which could act as autoantigens when presented to the immune system. We have shown this in the case of Sjögren syndrome type A (SS-A) and B (SS-B) antigens as well as cleaved α-fodrin [7, 8] in vitro. In vivo, such autoantigens could elicit autoantibody production and contribute to the initiation and propagation of autoimmunity [3] .Because apoptosis is a well-documented mechanism leading to salivary cell death, we hypothesized that the apoptotic products of salivary tissues may be detectable in the saliva of patients with SS. In patients with HIV/AIDS, the retrovirus or products also induces apoptosis, and patients may also suffer xerostomia due to diffuse infiltrative lymphocytosis syndrome (DILS).
The membrane-associated cytoskeleton protein fodrin (also known as non-erythroidspectrin) consists of α-and β-subunits of which the α-subunit is highly conserved and is 90% identical among species [5] .The function of fodrin is to provide internal structural support to the lipid bilayer of the cell membrane. Proteolysis of fodrin by caspases during apoptosis isinduced by a variety of stimuli and cytokines, notably tumor necrosis factor α (TNF-α) [11] .Apoptotic cleavage of the 240 kDafodrin at several sites can result in the generation of a 150 kDa amino terminal, a 120 kDacarboxy terminal, and a 35 kDa fragment during TNF-α induced apoptosis [4, 10, 12] .In studies reported using the NFS/ sld mouse model of SS, the purified 120 kDa fragment α-fodrin antigen was shown to induce proliferative T cell responses and the production of interleukin-2 and interferon-γ (IFN-γ) in vitro [4] . Furthermore, neonatal immunization with the 120 kDa antigen was shown to induce tolerance and prevent the development of autoimmune disease in the NFS/sld murine model. Sera from patients with SS and other autoimmune diseases may react positively with the purified 120 kDa antigen but there is little known about the distribution of the antigen in tissues. There are several reports that have evaluated the diagnostic value of the homologous autoantibodies with a wide range of efficacy depending upon the criteria used for patient selection and technical issues but not the autoantigen. Based on the NFS/sld mouse model, results show that the 120 kDa fragment of fodrin is only found in salivary tissue and is not detected in lung, liver, heart, kidney, pancreas, spleen, or brain. These results suggest that the immune response to 120 kDa α-fodrin could be important in stimulating the initial development of primary SS [4] . Other studies carried out in human salivary gland (HSG) ductal and acinar cells in vitro suggest a potential mechanism of autoantibody formation by showing that α-fodrin is cleaved following TNF-α induced apoptosis [7, 10] .Apoptosis yields a 120 kDa cleaved protein that is mobilized from within cultured salivary ductal cells and presented on the cell surface. The underlying rationale for the present study is that if the 120 kDa fragment of α-fodrin is produced and mobilized to the salivary cell surface in vivo and expressed following apoptosis, the cleaved fragment of α-fodrin may be expected to occur in saliva or detectable on salivary tissues obtained from patients with SS.
Methods

Subject recruitment and sample collection
Institutional Review Board approval from the University of Missouri-Kansas City and informed written consent was obtained from all individuals prior to this study. In the present study, tissues from 19 primary SS patients, 22 HIV/AIDS patients, and 16 healthy controls were examined. Patients with primary SS were selected using the classification system of the AmericanEuropean Consensus Group [13] . Patients were all under the care of a rheumatologist and were recruited through a local SS support group at St Luke's hospital in Kansas City and referred to the University of Missouri School of Dentistry dental clinic for this study. Patients with secondary SS were excluded due to the inability to standardize patient selection and testing, variation in diagnostic criteria applied and our inability to obtain sufficient numbers in each group. All patients with primary SS complained of xerostomia, had a history of Class III or IV Greenspan score from a labial salivary gland biopsy, keratoconjunctivitissicca with Schirmer's test of less than 4 mm and/or arthritis. These cases were well characterized, non-smokers, and all patients had at least one positive autoantibody (SS-A or SS-B) recorded previously. Saliva and plasma from healthy individuals seen in our dental clinic and from those with HIV/AIDS were also used as controls in this study. Controls were obtained from 8 healthy males aged 24-46 and 8 females aged 21-44 with no prior history of autoimmune disease or HIV/AIDS. Twenty-two patients (6 female aged 25-56 and 16 male aged 25-46) with a confirmed diagnosis of human immunodeficiency virus (HIV) infections were recruited from the University of Missouri-Kansas City dental clinic and Truman Medical Center.Two of the females and 7 of the males admitted to being smokers.
The histologic study also utilized archival biopsies confirming grading and lymphocytic focus score from 16 healthy controls reported previously and included in Table 1a and 1b [8] . Sixteen HIV patients from whom saliva was available, had received a broad range of anti-retroviral drugs, including protease inhibitors, while 6 of the HIV patients had not. None of the HIV/AIDS subjects had reported objective symptoms of hyposalivation nor was parotid enlargement observed upon physical examination. Pathology results on archival salivary biopsies from HIV patients and healthy controls were not statistically different (p > 0.05) [8] . This was not surprising since most HIV patients were receiving anti-retroviral therapy.
Salivary cell line and culture
The HSG is a well-studied ductal epithelial cell line that was obtained from an irradiated, but histologically normal human submandibular gland [14] .Although these cells exhibit an immortalized growth pattern, they retain an exocrine gland phenotype through expression of lactoferrin and amylase [15, 16] . The HSG cell line has been used as a model system to study salivary gland function [17, 18] .HSG cells, obtained originally from Dr. HyndaKleinman at the National Institute of Dental and Craniofacial Research (NIDCR), were cultured as follows and stored frozen in glycerol at passage 23-24 and later recovered for this study. Cells were cultured in Dulbecco's Modified Eagle Medium(DMEM) supplemented with 10% fetal bovine serum, penicillin (100 U/mL)/streptomycin (100 μg/ mL)in a humidified atmosphere of 95% air and 5% CO 2 at 37 °C. After 4 h culture in the presence of a combination of TNF-α (10 ng/mL) (R and D Systems, Minneapolis, MN) to stimulate apoptosis and cycloheximide (CHX) (10 µg/mL; Sigma-Aldrich, St. Louis, MO), 1x10 5 cells were harvested. Cells were dissociated with trypsin, harvested, and solubilized with gel loading buffer (62.5 mMTris-HCl, 2% SDS, 25% glycerol, 0.01% bromophenol blue, 0.05% v/v 2-mercaptoethanol, pH 6.8). The post-apoptotic sample containing cleaved α-fodrin was then incubated at 100 °C for 5 min prior to loading onto the gel as a marker for analysis by Western blot.
Saliva collection
Unstimulated saliva (0.5-2.00 mL) was collected from patients into a 50 ml plastic centrifuge tube (Falcon) by expectorating saliva passively as it accumulated over a 20 minute period following an oral rinse with fresh bottled water. Patients had not eaten for at least three hours prior to the collection which was carried out in the morning. Saliva samples were obtained from only 9 of 19 SS patients due to difficulties obtaining sufficient quantities of unstimulated saliva and its high viscosity in some patients. Plasma samples were obtained from all patients except one individual with SS. Due to these limitations, 9 saliva samples, 17 plasma samples, and 17 biopsies were analyzed for the presence of cleaved α-fodrinautoantigen in saliva and minor salivary gland parenchyma.
Western blot analysis
Whole saliva from SS patients, patients with HIV/AIDS and controls was centrifuged (5,000 rpm, 10 min) and the supernatant samples were aliquot and frozen at -85 °C until Western blot analysis. Salivary samples were thawed and placed in Millipore ultracentrifugation tubes and centrifuged at 5,000 rpm for 2 h at 4 ºC until the samples were concentrated to a volume of 50 µL. 2X gel loading buffer (pH 6.8) was mixed with samples and incubated at 100 ºC for 5 min.Samples were separated by electrophoresis on 10% SDS-PAGE gels with running buffer (25 mMTris, 19.2 mMglycerine, 0.1% SDS, pH 8.3) and the proteins were transferred to a Hybond-P membrane (Amersham Pharmacia Biotech Inc, Piscataway, NJ) with Tris/glycine buffer (20% methanol). After protein samples was transferred to the membrane, the membranes were blocked with 5% (w/v) skimmed milk powder in TBS (20 mMTris, 500 mMNaCl,pH 7.5) and then probed with a 1:1000 primary monospecific anti-α-fodrin antibody (Chemicon International, Inc., Temecula, CA) diluted in TTBS (0.05% Tween). Following washing with TTBS, bound antibodies were detected using a peroxidase-conjugated anti-mouse IgG (Pierce, Rockford, IL). After further extensive washing with TTBS, peroxidase reactivity was detected using chemiluminescence (Pierce, Rockford, IL immunoblots was performed with a GS-250 molecular imaging system (Bio-Rad, Hercules, CA).
Plasma collection and analysis
Plasma samples were obtained from all patients to detect autoantibodies targeting cleaved α-fodrin using an ELISA. ELISA was performed according to the manufacturer's recommendations (Genway Biotech, Inc. San Diego, CA 92121). Positivity for anti-α-fodrinIgG and IgA in this assay was established at a cut-off value of 6.25 U/mL by the manufacturer and results read on a microplate reader (Bio-Rad, Hercules, CA) were reported minus the value for the blank wells.
Immunoperoxidase assay
Labial minor salivary gland biopsies were fixed for 4 hours or overnight in 10% buffered formalin, dehydrated in graded alcohol, embedded in paraffin, sectioned at 5 µm, stained with hematoxylin and eosin and graded histologically for all patients as previously described [8] . Immunohistochemistry to detect cleaved α-fodrin in minor salivary gland biopsies was performed via the immunoperoxidase assay following the manufacturer's instructions (Vector Labs, Burlingame, CA). The primary antibody was a rabbit polyclonal antibody (2121 Asp 1185) recognizing the cleaved fragment of human α-fodrin (Cell Signaling Technology, Beverly, MA, USA) and a peroxidaselabeled secondary anti-rabbit IgG (#7074) with IgG controls. The primary antibody does not recognize full-length α-fodrin, only the cleaved product. To detect cleaved α-fodrin, specimens were rehydrated and washed in PBS prior to application of the immunoperoxidase assay as previously reported. Briefly, to unmask and expose antigens, sections were initially heated in 10 mM sodium citrate buffer (pH 6.0) for 2 min in a microwave at full power followed by 20 min of cooling. Endogenous peroxidase was quenched with 0.3% H 2 O 2 in PBS for 10 min and sections were blocked with Blocking Solution provided in the kit. Slides were then subsequently reacted with polyclonal antibodies (1:100) specific for cleaved α-fodrin (Asp 1185, Cell Signaling Technology, Beverly, MA, USA) and incubated overnight at room temperature. Next, after three further washes, sections were incubated for 2 h with a peroxidase-labeled secondary rabbit anti-mouse antibody (Zymed Laboratories Inc., San Francisco, CA) and color development was achieved by incubation for 1 to 5 min with diaminobenzidinetetrahydrochloride (DAB) reagent. Slides were counterstained with hematoxylin solution and excess hematoxylin was washed away with deionized water. Sections were finally dehydrated in graded alcohol followed by two xylene washes before they were also photographed using a TE300 photomicroscope (Nikon Instruments Inc., Melville, NY). Counting of immunostained cells was performed on salivary gland tissue samples containing ducts, acini, and lymphocytic infiltrates from SS patients and healthy controls without lymphocytic infiltrates by reacting tissue sections with polyclonal antibodies specific for cleaved α-fodrin using a modification of the method described by Ohlsson et al. [2] .
Statistical analysis
Based on the property of continuous variables, and that each SS and control individual sample contained both an anti-α-fodrin ELISA IgA and IgG result, the reliability of IgA and IgG was measured with Pearson's correlation using criteria for strength of correlation: small (0.1) medium (0.3) large (0.5).A paired t-test was applied to detect the difference between IgA and IgG and t-tests for two independent groups were used to determine whether there was a significant difference between the positive and negative ELISA results for IgA and IgG. Levene's test was applied to detect equality of variances in this test. Meanwhile, a t-test was also used to identify whether the difference of anti-α-fodrin (IgG and IgA) exists between Sjögren Syndrome and healthy individuals (these data were not available for HIV/AIDS patients). Spearman's rank correlation was used to determine the association of α-fodrinautoantigen IHC with salivary grade and biopsy focus score since they are ordinal variables.The Mann-Whitney U test was applied to detect whether Sjögren Syndrome is different from healthy individuals and HIV positive individuals with respect to salivary grade, biopsy focus score and IHC. Tukey's post hoc test was used to identify the pairwise significance of image band α-fodrindensity (continuous variable) results for controls, SS-positive, and SS-negative groups after the overall significance was determined bya one-way ANOVA. Data were analyzed using SPSS® statistical software, version 15.0 (SPSS Inc., Chicago, IL, USA). A p-value of < 0.05 was used to indicate statistically significance.
Results
Salivary α-fodrin antigen
Western blot analysis of the salivary samples from the 9 saliva specimens obtained from SS patients revealed that 7 (77.0%) of 9 individual saliva specimens contained the cleaved 120 kDa α-fodrin fragment. Three of these were barely visible on the preliminary gel; however, and there was insufficient sample to replicate them. Of the remaining four samples which were replicated, all were positive by western blot. Figure 1 shows a typical positive example and Figure 2a compares the results of the densitometry by image analysis. Figure 2b is a bar graph comparing the mean alpha fodrinautoantigen levels detected in saliva samples from the 16 healthy individuals with the 9 patients with SS.Cleaved α-fodrin was not detected in saliva from the 22 HIV/AIDS patients tested (data not shown). The positive control for the Western blot analysis consisted of the cleaved products of the HSG cell line stimulated by TNF-α in vitro by methods previously reported [7, 10] . The Western blot of the cleaved products of HSG TNF-induced apoptosis showing cleaved α-fodrin, PARP and procaspases, is presented in Figure 4 . Figure 1 shows the cleaved α-fodrin product, which was also detected by immunohistochemistry in biopsies of 8 of 16 SS (50%) patients tested. Immunoperoxidase staining (IHC) was primarily associated with ductal cells and occasional infiltrating CD4+ T lymphocytes in SS sections of minor salivary gland biopsies confirming previously published research [10] . Figure 3 is a photomicrograph that shows representative minimal staining of α-fodrin in a minor salivary gland biopsy from a healthy patient (Fig. 3a) and 2+ staining in diseased salivary tissue from an SS patient (Fig 3b) . In sections from SS patients in Fig. 3b , cleaved apoptotic product, α-fodrin, is strongly associated with ductal (D) and acinar (A) epithelia. Counting of labeled ductal, acinar, and infiltrating mononuclear cells by two observers showed some variation in staining of ductal cells between patients (41%, SD = 18.0%) and a significant difference (p < 0.001) between the mean of SS patients compared with healthy controls (19%, SD = 8.0%). In the case of acinar cells, 27% (SD = 11.0%) stained positively in SS and in 11% (SD = 6.0%) of healthy controls, a difference which was also significant (p < 0.001). In the case of staining of the infiltrating lymphocytes, 31% (SD = 14%) of lymphocytes were stained in patients with SS, while 12% of lymphocytes were stained in controls (SD = 3%). This difference between SS and healthy controls was significant (p < 0.001).
Immunohistochemistry
Plasma anti-α-fodrin autoantibodies in primary SS patients (Table 1a and 1b)
Analysis of plasma samples for anti-α-fodrin antibodies was carried out in 19 SS patients and 15 had IgG levels greater than those from healthy control patients. Plasma from 10 patients (52.6%) had detectable levels of anti-α-fodrin IgA. In all patients, the IgA levels ranged from 0.0 to 12.4 U/mL. Further, 10/19 (53%) patients provided plasma with elevated levels of anti-α-fodrinIgG. Antibody concentration ranged from 0.0 to 14.5 U/mL. Of the 7 patients who produced adequate quantities of saliva suitable for detection of cleaved α-fodrin by Western blot and who also had ELISA performed on plasma to determine autoantibodies, only 4 of the 7 saliva samples tested had detectable levels of cleaved α-fodrin antigen by Western blot. Of these 4 patients, one patient produced both classes of plasma autoantibodies (both IgA and IgG) specific for cleaved α-fodrin antigen. Saliva from 2 of the remaining 3 patients (67%) contained no detectable levels of cleaved α-fodrin protein in saliva but all 3 produced detectable levels of both IgA and IgG anti-α-fodrin antibodies. By contrast, 16 of 17 SS patients had a positive biopsy (histologic Chisholm and Mason grade > 2+) and when evaluated for the presence of cleaved α-fodrin antigen in biopsy sections stained by immunohistochemistry, 8 were positive at varying levels with staining primarily associated with the ductal epithelium ( Figure 3) .
Results of Statistical analysis
IgA and IgG and α-fodrin are moderately correlated with a Pearson's correlation coefficient of 0.506. A paired test indicated The left lane contains MW marker of cleaved α-fodrin. Apoptotic products fodrin (220 kDa), α-fodrin (150 kDa), and cleaved α-fodrin (120 kDa) are detected in the right lane. As seen by the positive band in lane 4 (right), cleaved 120 kDa -fodrin, which is a substrate of caspase 3, is detected in saliva samples from 4 SS patients. None of the 22 HIV patients or 16 healthy controls had detectable cleaved α-fodrin in their saliva. Saliva from 4 of the 9 SS patients contained clearly detectable cleaved 120 kDa fragment as shown above as opposed to intact α-fodrin suggesting that this is cleaved in ductal cells and released from the ductal cell surface into the salivary duct and oral cavity. Saliva from an additional SS patient was also positive but produced insufficient saliva to be replicated and thus was included with the negative SS samples in the image analysis in Figures 2a and 2b 
Healthy (a)
Sjögren's syndrome (b) Figure 3 : Photomicrographs of minor salivary glands showing cleaved α-fodrin immunostaining of tissues from a healthy individual (Fig. 3a) and a patient with SS (Fig. 3b) . Cleaved α-fodrin staining (tan shade) was detected in situ using immunohistochemistry and immunoperoxidase staining. In SS (Fig. 3b) , cleaved α-fodrin autoantigen is strongly expressed on the ductal epithelium (D), on sporadic acinar cells (A) and strongly associated with infiltrating mononuclear cells (IMC). Cleaved α-fodrin autoantigen was rarely detected in healthy control salivary gland biopsies or those with HIV/AIDS (Table 1) ; similarly, HIV/AIDS patient were also significantly different from patients with SS with respect to salivary grade, biopsy focus score and IHC (Table 1 ). Tukey's post hoc test indicated the density of the image band detected in saliva of SS patients with a positive western blot were significantly greater than those SS patients with a negative western blot or control groups. As expected, there was no significant difference between SS patients with a negative western blot and the healthy control group (Figure 2b ).
Discussion
Sjögren syndrome (SS) is a systemic autoimmune disease with an unknown mechanism but which has been associated with the production of a range of autoantibodies and autoantigens. Most of the autoantibodies have not been directly related to cell damage in specific tissues although autoantibodies have been detected in salivary gland tissue, they are not considered the cause of salivary gland destruction.
In the current study, we determined the presence of both plasma autoantibodies in SS patients using an ELISA and α-fodrinautoantigen in saliva from the same patients, using Western blot analysis with molecular imaging and confirmed with a specific monospecific antibody by immunohistochemistry on minor salivary gland biopsies. All patients received a minor salivary gland lip biopsy to grade the level of disease histologically and to detect cleaved α-fodrinautoantigen expressed in both saliva and minor salivary gland tissues. This was a small study compromised by the inability of many of the recruited patients to produce sufficient saliva suitable for analysis by the western blot method. This was not surprising since most of the SS patients were post-menopausal women, which highlights the lack of sensitive assays available to detect salivary gland damage early during the course of the disease. However, of importance, the cleaved α-fodrinautoantigen fragment was demonstrated semiquantitatively in salivary gland parenchyma of 8/16 patients by immunohistochemistry and detected in the saliva of 4/9 of the same patients tested. The remaining 10 patients produced insufficient saliva for analysis by the described methods. This finding supports evidence from previous studies that the cleaved 120 kDa α-fodrinautoantigen detected in saliva is related to the level of apoptotic cell death and grade of disease in the salivary glands, and as such, this autoantigen, not the autoantibody, may be a useful marker of cell damage [5, 7, 8, 10] . As expected, and shown by multiple previous studies, the autoantibodies against the cleaved α-fodrinfragment are of low diagnostic sensitivity, although, in support of our mechanistic immunologic hypothesis, all patients who produced a positive IgG or IgA autoantibody, also demonstrated the presence of the autoantigen in the salivary tissues by immunohistochemistry [19] .
Accumulating evidence shows that at least one mechanism of salivary gland destruction involves apoptosis although the specific pathway has not been confirmed in vivo. Our previous results supported the role of α-fodrin as one of several autoantigens associated with SS and suggested a potential mechanism. We have shown by cell fractionation and immunofluorescence that the 120 kDa α-fodrin fragment cleaved from fodrin is relocated to the surface of apoptotic HSG cells in vitrowhen stimulated by TNF-α [7, 10] .It is also noteworthy from the current study that only the cleaved form was detected in saliva. This finding is consistent with presumed mechanism and suggests that cleavage occurs at the level of the salivary ducts probablybefore secreted into saliva. It may be insightful mechanistically to evaluate SS-A, SS-B, caspase 3 protein expression in concert with cleaved α-fodrin in saliva, especially using a highly sensitive plasmon grating nanotechnology [20] , which has been recently reported for infectious disease detection, or mass spectrometry. In this way, small volumes of saliva could be evaluated for multiple antigens simultaneously.
The detection of cleaved α-fodrinautoantigen is important because several researchers have detected homologous autoantibodies against this protein in primary and secondary SS patients and in murine models of SS [5] . The latter discovery, published in Scienceby Haneji et al in 1997, led to the elucidation of the nature of the autoantigen in the murine system and based upon the sequence, showed its homology with the human cytoskeletal protein, α-fodrin. However, to our knowledge, our present study is the first to demonstrate the cleaved 120 kDa α-fodrinautoantigen in human salivary glands and its secretions. Previous studies by our group have shown that salivary ductal and acinar cells strongly express cleaved α-fodrin during apoptosis of salivary ductal and acinar cells in vitro. Several well-known autoantigens, including SS-A/SS-B, caspase 3, and α-fodrin are cleaved during apoptosis and transported to the cell surface [10] .Collectively, these results point to a strong association between cleaved α-fodrin and other markers of autoimmune disease known to play a role in apoptosis such as SS-A, SS-B and activated caspase-3 also confirmed by our group by DNA fragmentation [7] .
As stated earlier, in an in vitromodel using HSG cells that α-fodrin, caspase-3, poly(ADP-ribose) polymerase protease (PARP), SS-A, and SS-B were all cleaved in response to stimulation by TNF-α, a known inducer of apoptosis [21] .Therefore, it is possible that TNF, which is increased systemically in SS, contributes in vivo to apoptosis and destruction of salivary gland tissue. TNF-α and other cytokines such as IFN-γ are known to be increased in vivoin the parenchyma of salivary and lacrimal glands of patients with SS [22] [23] [24] [25] [26] .The cellular source of TNF in the salivary glands is unknown, however, although it is presumably released by infiltrating CD4 lymphocytes. Interestingly, all proteins except PARP are cleaved in vitroand transported to the ductal or acinar cell membrane; PARP, however, is cleaved but remains in the intracellular space [21] .Perhaps this intracellular location of PARP where it appears protected from antigen processing by the immune system, is one factor contributing to why PARP is infrequently associated with autoantibody production in SS.
Haneji et al. first reported the presence of a 120 kDa organspecific α-fodrinautoantigen in a study of murine tissues. This antigen was purified from salivary gland tissues in the NFS/sld mouse model of human SS and the amino-terminal residues of the detected antigen were found to be identical to those reported for human α-fodrin protein [5] .This purified antigen was shown to induce proliferation of murine T cell responses in this same murine model of SS. Secondly, in the same report, ninety-five percent of sera from patients with SS examined reacted positively with purified α-fodrinautoantigen and recombinant human α-fodrin protein providing the first evidence for a novel murine autoantigen with the homologous autoantibody occurring in humans with autoimmune diseases. There have been several controversial studies, where the specificity of the serologic response to α-fodrin has been unclear. Some reports from studies on serum or plasma from patients with secondary SS, accompanied by systemic lupus erythematosus or rheumatoid arthritis, suggested they do not contain autoantibodies while other studies in secondary SS reported they were detected. The reason for these discrepancies may be in the characterization of patients or technological differences.
Preliminary evidence suggests that the 120 kDa cleaved α-fodrin fragment may be important in stimulating the initial development of autoantibodies in vivo. Anti-cleaved α-fodrin (Asp 1185) antibody is a reagent, which only reacts with the 120 kDa cleaved α-fodrin fragment but not with intact fodrin antigen. The application of this antibody to detect the cleaved α-fodrin products in labial salivary glands and saliva of patients with SS provides direct evidence that the cleaved 120 kDa α-fodrin fragment is produced by the same cells in salivary tissue during apoptosis since apoptosis and autoantigen co-expression has been shown by immunofluorescence [7] .It is tempting to speculate that the cleaved 120 kDa α-fodrin fragment is rendered immunogenic upon cleavage during apoptosis. Such cleaved products could then be presented to ductal epithelial or endothelial cells, which express HLA-DR antigens or CD40, and could then undergo antigen processing. This could result in an immune response with T cell proliferation and the production of the autoantibodies detected in many SS patients [21] .This observation also provides a possible explanation for a central role of epithelial cells in SS implied by the location of the periductal and perivascular location of lymphocytic infiltrates in salivary gland ducts and vessels [21, 27] .It is interesting that cleaved PARP fragments have been reported on the ducts and acini but minimally detected in the area of the lymphocytic infiltrate compared with α-fodrin [11] . This is consistent with the proposal that PARP, a nuclear antigen, we have shown is not expressed on the cell surface during apoptosis and therefore not expected to undergo antigen processing by infiltrating lymphocytes [7] .
In contrast, Chen et al. assessed the existence of SS-A, SS-B, and α-fodrin antigen in sera of individuals with primary SS, secondary SS, and non-Sjögrensicca syndrome (NSS). Using an ELISA, they showed, surprisingly, that the presence of serumα-fodrinautoantigen was more specific in patients with NSS versus primary and secondary SS [28] .The authors suggested this could be an early marker of SS but at this time, a large group of patients with SS and NSS patients need to be followed to determine if the NSS group develop autoimmune SS. These authors did not examine saliva. Collectively, these observations suggest that the cleaved antigen fragment could be a marker for SS.
Autoantibodies against α-fodrin have been found in many patients with primary and secondary SS; some of these patients lacked anti-SS-A antibodies in their serum [29, 30] .Witte et al. further reported α-fodrin autoantibodies as markers for SS in humans [31, 32] .Autoantibodies recognizing α-fodrin antigen was reported in another study in the serum of 95.3% of individuals with primary SS but not in patients with secondary SS or in healthy controls [5] .One of the objectives of this study was to determine the specificity of the relationship between the production of autoantibodies and the presence of the autoantigen in saliva but the data are limited and a much larger study is essential to elucidate this further. Previous clinical studies have shown circulating autoantibodies in SS patients. In one study, plasma autoantibodies were demonstrated in 20% of 200 patients with primary SS, with monoclonal IgG predominating [9] .While the measurement of anti-α-fodrinIgG levels could only be performed in 17 out of 19 SS patients, 15 of these patients had IgG levels specific for α-fodrin greater than those found in the unstimulated saliva of healthy patients. Interestingly, the levels of anti-α-fodrin IgA detected in all 19 SS patients were 10-fold lower than the reported value in normal individuals [10, [33] [34] [35] . Explanations for this discrepancy in unexpectedly low IgA values is unlikely to be due to collection, storage, and processing of samples as this was accomplished under identical conditions and at the same time as the controls. Possible explanations, however, include the presence of concomitant periodontal disease or immune complexes, which we did not examine, variations based in the degradation of IgA by bacterial proteases or binding of IgA to bacteria and loss during centrifugation. Moreover, in the presence of the cleaved antigen, autoantibodies could be blocked by homologous antigen and rendered undetectable. Finally, it could be due to low sensitivity of the ELISA or reduced saliva volume [36] .
The current study has several limitations, some already discussed above. The detection of α-fodrin by immunoblot involved only nine patients and a larger sample size would have conferred more power to the investigation. Likewise, our testing of IgG and IgA by ELISA was performed on a relatively small sample size. Despite this, our results show for the first time that the 120 kDa fragment of α-fodrin is a specific autoantigen present in the saliva of some patients with SS and worthy of further investigation. It would also be of interest to test lacrimal fluids for the presence of the autoantigen since lacrimal fluid, although of very small volume, is less complex and not compromised by the contents of the oral cavity and the multiple different glands that produce saliva as well as leakage via the gingival crevices. Multiple different aqueous or serous salivary glands, some of which require stimulation, make collection challenging and the resulting saliva complex. The discovery of cleaved α-fodrin as a potential marker of disease in saliva could form the basis of a novel diagnostic test following confirmation using saliva and blood collected from patients in larger studies in SS and NSS patients and carried out over the course of the disease. The study could benefit from the application of a more sensitive technology given the difficulty in obtaining saliva in sufficient volumes from patients in advanced stages of disease. At present, there are no specific markers for Sjogren syndrome. Interleukin 6 (IL-6) has been suggested. However, IL-6 is only another nonspecific marker as higher IL-6 levels can also be present in many other inflammatory and autoimmune conditions [34, 35] .
Conclusion
The results of this study, carried out in well-characterized patients, support our hypothesis that α-fodrin antigen is found in the saliva of primary SS patients and expressed on ductal epithelia; however, further studies are necessary to confirm these findings in a larger group of patients with primary and secondary SS representing all stages of disease. Further, we suggest that cleaved α-fodrin may be a potential marker of primary Sjogren syndrome but emphasize the need for further studies that consider multiple autoantigens simultaneously. If these findings are confirmed, a sensitive diagnostic tool to detect cleaved α-fodrin and possibly other autoantigens in saliva at an early stage of disease could be a useful adjunct to monitor disease progression and treat patients before exocrine destruction has occurred.
